Walgreens launches website that features more than 50 completed Walgreens outcomes studies

Company collaborates with academic institutions, including Johns Hopkins Medicine, Scripps Translational Science Institute, University of California, San Francisco – School of Pharmacy and the University of Chicago Medicine to improve health and wellness in America

DEERFIELD, Ill., 2017-Aug-16 — /EPR Retail News/ — Walgreens today (15 August 2017) announced the launch of its Center for Health & Wellbeing Research, a website that features more than 50 Walgreens outcomes studies completed over the past six years. Areas of research include access to care and patient experience, adherence and clinical outcomes, digital health and member engagement, health care costs, HIV and specialty pharmacy, vaccinations and more.

Visitors to the site – https://www.walgreens.com/research – will find summaries, links and original documents related to company research reports and studies that have been published in peer-reviewed medical and health care publications, as well as presented at scientific and industry conferences.

“We are thrilled to be unveiling the Walgreens Center for Health & Wellbeing Research,” said Harry Leider, M.D., chief medical officer and group vice president, Walgreens. “Our goal is, through scientific research, to help improve patient care and outcomes while lowering health care costs. We are dedicated to providing value to health care on a national scale and the Walgreens Center for Health & Wellbeing Research will showcase the work we are doing every day to advance that mission.”

Walgreens is working with academic institutions on its research, including Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health, the Scripps Translational Science Institute, the University of California, San Francisco – School of Pharmacy and the University of Chicago Medicine. The institutions provide guidance, specialized expertise, and industry insights that contribute to the Walgreens outcomes research agenda. Researchers from Walgreens and these institutions actively collaborate on a variety of research studies.

“Walgreens has been a valued partner in a long-standing and productive collaboration, which has given our clinical and research faculty the opportunity to develop, implement and evaluate novel programs to reach patients where they are to improve their access to quality care,” said Jeanne M. Clark, M.D., M.P.H., a professor of medicine at the Johns Hopkins University School of Medicine and the Johns Hopkins medical director for its collaboration with Walgreens. “We are looking forward to continuing our work together.”

The Walgreens Center for Health & Wellbeing Research is led by a team of more than 25 Walgreens health services researchers, clinicians, statisticians, public health practitioners, actuaries and data scientists, including:

  • Harry L. Leider, MD, MBA, FACPE, chief medical officer and group vice president
  • Michael S. Taitel, PhD: senior director of health analytics, research and reporting
  • Heather Kirkham, PhD, MPH: director of health analytics, research and reporting

Recent research from the team includes:

  • A study of pharmacy patients enrolled in Medicare Prescription Drug Plans (Medicare Part D), published in Patient Preference & Adherence, which found that patients who were late to refill prescriptions and who received reminder calls from local Walgreens pharmacists, demonstrated nearly 23 percent greater adherence within the first 14 days of the expected refill date.1
  • A study presented at the 22nd Annual International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting in Boston, exploring length of therapy and factors associated with HIV pre-exposure prophylaxis (PrEP) medication adherence, which demonstrated significantly higher adherence among older age groups, males, users of HIV-specialized services and those with private insurance. The study found that patients used PrEP on average for seven to eight months in the first year.2
  • A study from Walgreens and Inovalon which examined the effectiveness of the Walgreens Connected Care Cystic Fibrosis (CF) program compared to a matched sample of control patients. The study found that CF patients have better outcomes when enrolled in a pharmacy-based comprehensive therapy management program. The study was presented at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida.3
  • A collaborative study with the Scripps Translational Science Institute4 published in the Journal of Medical Internet Research, which evaluated health data self-tracking characteristics of individuals enrolled in the Walgreens Balance Rewards for healthy choices® (BRhc) program, including the impact of manual versus automatic data entries through a supported device or apps. The study demonstrated that 77 percent of users manually recorded their activities and participated in the program for an average of five weeks. However, users who entered activities automatically using the BRhc supported devices or apps remained engaged four times longer and averaged 20 weeks of participation.

About Walgreens

Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

http://news.walgreens.com/press-releases/general-news/walgreens-study-demonstrates-pharmacy-interventions-can-help-improve-adherence-for-medicare-part-d-patients.htm#_ftn1

http://news.walgreens.com/press-releases/general-news/walgreens-to-present-research-from-five-clinical-studies-at-international-society-for-pharmacoeconomics-and-outcomes-research-annual-international-meeting.htm

https://www.walgreens.com/images/adaptive/pharmacy/healthcenter/b2b/Assessing_the_Impact_of_a_Pharmacy-Based_Therapy_Management_Program_on_Adherence_and_Healthcare_Utilization_in_Cystic_Fibrosis.pdf

http://news.walgreens.com/press-releases/new-research-from-walgreens-and-scripps-translational-science-institute-demonstrates-the-value-of-automated-health-tracking.htm

Contact(s):
Scott Goldberg
847-315-7649
scott.goldberg@walgreens.com
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreens

Source: Walgreens

75% of Walgreens mental health platform visitors who complete screenings take active steps for follow-up

One year into initiative and collaboration with Mental Health America, data shows nearly 75 percent of Walgreens visitors who complete screenings take active steps for follow-up

DEERFIELD, Ill., 2017-May-25 — /EPR Retail News/ — One year after Walgreens launched its mental health initiative and collaboration with Mental Health America (MHA), data shows nearly 75 percent of visitors to the digital platform who have completed screenings are also taking active steps for follow-up. The Walgreens platform is also helping to reach a broader demographic of consumers interested in mental health resources.

Visitors to the Walgreens mental health answers site (www.walgreens.com/mentalhealth) can readily access a selection of free online screening tools offered through MHA’s website, including those for depression, anxiety, bipolar disorder, PTSD and others. An analysis of non-identifiable screening data from the campaign’s first year shows that of visitors who have completed an online screening offered through MHA, those originating from the Walgreens platform are:

  • More likely to want a referral to someone who can help (37 percent vs. 19 percent)
  • More likely to take an anxiety screening (26 percent vs. 11 percent) or PTSD screening (9 percent vs. 3 percent)
  • Walgreens site visitors are also older (47 percent over age 35 vs. 17 percent for MHA) and more likely to be caregivers (29 percent of Walgreens visitors vs. 9 percent for MHA)

“One of our primary objectives when first launching this program was to help meet the growing need for resources and access to care,” said Harry Leider, M.D., and chief medical officer for Walgreens. “We’re proud to know that the tools and services we’re offering, along with Mental Health America and its community based resources and screening program, are enabling more people to seek answers or help. We look forward to finding more ways to work together, and with other providers and partners to address the many challenges facing both patients and our mental health system today.”

Of the nearly 75 percent of Walgreens visitors who have taken active steps after completing MHA screenings, more than 30 percent say they found treatment, 1-in-4 (24 percent) discussed their results with family, friends or a healthcare professional, and approximately 20 percent have sought additional information.

“Mental Health America is pleased to be working with Walgreens on this important initiative,” said Paul Gionfriddo, president and CEO, Mental Health America. “Our online screening program is often a critical first step for people who have mental health concerns, and because of this collaboration, we’ve seen a more diversified group of visitors to our site, including older generations and caregivers, as well as people who have had a prior mental health diagnosis.”

MHA to add Walgreens Pharmacy Chat to website

Visitors to MHA’s website will soon have easy access to Walgreens pharmacists 24/7 for assistance with medication-related questions or concerns. Walgreens Pharmacy Chat, which offers online access to Walgreens pharmacy staff for secure, 1-on-1 chats, will be available via hyperlink on www.mentalhealthamerica.net this summer.

About Walgreens

Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

Contact(s):

Jim Cohn
847-315-2950
jim.cohn@walgreens.com
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreens

Source: Walgreens

Walgreens and STSI study suggest that automated health tracking can improve long-term health engagement

Connected devices and apps eliminating the need for manual tracking drive better long-term engagement in healthy activities, study shows

DEERFIELD, Ill., 2016-Dec-13 — /EPR Retail News/ — Walgreens today (December 12, 2016) announced findings from a collaborative study with the Scripps Translational Science Institute (STSI) suggesting that automated health tracking can significantly improve long-term health engagement. The study examined utilization patterns of participants in Walgreens Balance Rewards for healthy choices® (BRhc), an industry leading, self-monitoring program that allows members to track health activities and receive incentives for continued tracking and healthy behaviors. It explored the impact of manual versus automatic data entries through a supported device or via apps, the study results were recently published in the Journal of Medical Internet Research.1

The researchers examined activity tracking data – including exercise, weight, sleep, blood pressure, blood glucose data recorded, tobacco use and oxygen saturation – from more than 450,000 BRhc members in 2014. After identifying users with sufficient follow-up data, the study explored trends in participation over time. The results demonstrated that 77 percent of users manually recorded their activities and participated in the program for an average of five weeks. However, users who entered activities automatically using the BRhc supported devices or apps remained engaged four times longer and averaged 20 weeks of participation.

“This is the first chapter of a remarkable collaboration with Walgreens, enabling us to understand real world connectivity with mobile device health applications, along with behavior and outcome patterns, in an exceptionally large and diverse cohort,” said Eric Topol, MD, director, STSI.

“Consumers are increasingly more engaged in their own healthcare and wellness. Digital technology that enables easy data tracking of healthy behaviors, combined with incentives, and trusted professional support, provide additional motivation for our customers to more easily manage their health,” said Harry Leider, M.D., chief medical officer, Walgreens. “We’re especially encouraged by the results of this study. In the two years since it was initiated, we’ve seen a shift from the majority of members in the program tracking their activities manually, to most now tracking them automatically. We’re pleased to continue our relationship with Scripps to advance our work in a way that results in a positive impact on behaviors and outcomes.”

The Walgreens Balance Rewards for healthy choices program can be accessed either online or through the Walgreens mobile app. One of the main features of the program is the use of existing consumer incentives to motivate voluntary participation. Through participation in BRhc, members receive loyalty points redeemable for discounts on purchases. For more information about Walgreens Balance Rewards for healthy choices, please visit https://walgreens.com/healthychoices.

This research was supported in part by the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences through a grant UL1TR001114, and a grant from the Qualcomm Foundation.

STSI is a National Institutes of Health-sponsored site in San Diego that merges the considerable biomedical science expertise of The Scripps Research Institute with Scripps Health’s exceptional patient care and clinical research capabilities. This innovative research partnership is leading the effort to translate wireless and genetic medical technologies into high-quality, cost-effective treatments and diagnostics for patients.

About Walgreens

Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens omnichannel business includes Walgreens.com and VisionDirect.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

1 Ju Young Kim, Nathan E Wineinger, Michael Taitel, Jennifer M Radin, Osayi Akinbosoye, Jenny Jiang, Nima Nikzad, Gregory Orr, Eric Topol, Steve Steinhubl. Self-Monitoring Utilization Patterns Among Individuals in an Incentivized Program for Healthy Behaviors. J Med Internet Res 2016 (Nov 17); 18(11):e292. http://www.jmir.org/2016/11/e292/

Contact:

Walgreens
Scott Goldberg
(847) 315-7649
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreens

Source: Walgreens

Accessible dermatological information care and treatment through new skin care answers platform launched by Walgreens

DEERFIELD, Ill., 2016-Sep-20 — /EPR Retail News/ — The average wait time for patients looking to see a dermatologist in the U.S. is nearly 29 days, and in some areas, can exceed several months.1 To help meet the growing need for skin care resources and accessible care and treatment, Walgreens today (September 19, 2016) is launching a new skin care answers platform available through Walgreens.com and the Walgreens mobile app.

The platform (Walgreens.com/skincareanswers) features informational resources and content, and will also enable visitors to obtain extended skin care, including the Dermatologist On Call teledermatology service available through Iagnosis, which offers online dermatology consultations with U.S.-based, board-certified specialists.

Greg Orr, Walgreens vice president of digital health, said, “More than 2 million people visit our digital channels each day, and this is another way we can help address access challenges by giving our customers more convenient channels and resources to meet their health care needs.”

The skin care platform includes:

  • DermatologistOnCall®, the nation’s largest teledermatology-focused telehealth network offered by Iagnosis, for online dermatology scheduling and consultation
  • Information about common skin conditions such as acne and eczema from content partner and the leading source of health care information, WebMD
  • Basic skin and product recommendations through Walgreens Pharmacy Chat, which offers live online chat conversations 24/7 with members of Walgreens pharmacy staff

“This is another example of combining innovation and convenience to deliver tools and services that help deliver quality and affordable care to our customers anywhere, anytime,” said Harry Leider, M.D., Walgreens chief medical officer. “The teledermatology offering and collaboration is a natural extension of some of the services we already provide and can serve as a resource for screening and potential early diagnosis of a variety of skin conditions.”

Iagnosis’ DermatologistOnCall network of dermatology specialists can provide diagnoses and personalized treatment plans for more than 3,000 medical conditions affecting the skin, hair and nails, typically within 24 hours of the patient submitting their online visit. Patients who have created an online profile may upload photos of their skin condition via the private and secure platform, receive relevant answers to medical questions and select to receive care from a provider licensed in their state. The cost per online consultation is $59.

“We are very excited to announce this relationship with Walgreens, which has shown innovative leadership in embracing telehealth applications that deliver a high clinical quality standard to its customers,” said Dave Zynn, chief executive officer of Iagnosis. “Consistently, 98 percent of Dermatologist On Call patients say they’d recommend the service to a family member or friend, and we look forward to serving Walgreens customers as they look for solutions that support their health and well-being.”

For more information, visit: http://walgreens.com/skincareanswers.

About Walgreens

Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 8 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,173 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens omni-channel business includes Walgreens.com and VisionDirect.com. More than 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

About Iagnosis

Iagnosis, Inc. is focused on delivering faster healthcare treatment to patients through web-enabled solutions. Its flagship product, DermatologistOnCall®, is best-in-class for helping board-certified dermatologists in the U.S. offer patients convenient 24/7 online and mobile access to affordable, high-quality skin, hair and nail medical care. Iagnosis has been recognized in the industry for its innovation and high patient satisfaction ratings, and the company actively partners with physician practices, health systems, retailers, and other organizations to provide comprehensive and personalized care solutions to patients. Visit www.iagnosis.com for corporate information.

1 IBISWorld Industry Report OD4168 Dermatologists in the U.S., July 2015

Contacts:

Walgreens
Alyssa Bronikowski
(847) 315-8144
http://news.walgreens.com
@WalgreensNews
facebook.com/Walgreen

Source: Walgreens

Recent studies show Walgreens digital health resources help drive better medication adherence

DEERFIELD, Ill, 2016-Sep-14 — /EPR Retail News/ — Two of Walgreens widely adopted digital health resources are helping to drive better medication adherence among users, according to two recent company studies.

Walgreens research shows that those over 50 years of age who track activities through its Balance® Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, are more adherent to their medication therapies. A separate Walgreens study found that the pill reminder feature within the Walgreens mobile app is also demonstrating better optimal adherence[1] among users.

“People increasingly want to become more engaged in their own health care, and with Walgreens digital health offerings, we give our customers the ability to positively impact their behaviors and overall health,” said Harry Leider, M.D., chief medical officer, Walgreens. “These latest studies show how active participation and use of digital tools can benefit the user. They can also provide incentives for health plans, employers and payers by helping to reduce health care costs among members.”

Research on Balance Rewards for healthy choices and patients over 50
This study examined the relationship between BRhc engagement and adherence to antihypertensive, oral antidiabetic and antihyperlipidemic medications for patients ages 50 and older. The findings concluded that tracking physical activity four or more times per week were associated with significantly higher – optimal adherence to antihypertensive and antihyperlipidemic medication.[2] In addition, tracking blood pressure twice or more per week or tracking blood glucose once or more per week was associated with significantly better adherence to antihypertensive and oral antidiabetic medications.

Specific findings included:
 

  • Among BRhc members tracking physical activity, Walgreens observed greater rates of optimal adherence: 11.2 percent higher for antihypertensives, 5.1 percent higher for oral antidiabetics and 4.5 percent higher for antihyperlipidemics.
  • Among BRhc members tracking blood pressure or blood glucose, Walgreens observed greater optimal adherence: 6.8 percent higher for patients taking antihypertensives and 12.3 percent higher for oral antidiabetics.

The Walgreens retrospective cohort study examined patients who filled an antihypertensive, oral antidiabetic or antihyperlipidemic medication among those 50 years old or greater, between March and October 2014.

Research on mobile pill reminders
The other Walgreens study examined the linkage between patient forgetfulness and non-adherence to medications, and the effectiveness of a mobile pill reminder feature. The research found that utilization of the Walgreens mobile app pill reminder was associated with significantly higher optimal adherence to oral antidiabetic, antihypertensive and antihyperlipidemic medications.[3]

Results showed:

  • Among those who used the mobile pill reminder app, Walgreens observed greater optimal adherence: 12.3 percent higher for oral antidiabetics, 11.3 percent higher for antihypertensives and 9.1 percent higher for antihyperlipidemics.

To perform the study, Walgreens took a group comprised of patients who used the pill reminder and had oral antidiabetic, antihypertensive or antihyperlipidemic medications between an index period of January 2014 and September 2014 and compared to a control group comprised of those who did not use the pill reminder.

About Walgreens
Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 8 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,173 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens omnichannel business includes Walgreens.com and VisionDirect.com. More than 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

Media Relations:

To contact Walgreens media relations, please email media@walgreens.com or call 847-315-2921.

Source: Walgreens

Walgreens: pill reminder feature and activity tracking drive better medication adherence among pharmacy patients

DEERFIELD, Ill, 2016-Sep-13 — /EPR Retail News/ — Two of Walgreens widely adopted digital health resources are helping to drive better medication adherence among users, according to two recent company studies.

Walgreens research shows that those over 50 years of age who track activities through its Balance® Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, are more adherent to their medication therapies. A separate Walgreens study found that the pill reminder feature within the Walgreens mobile app is also demonstrating better optimal adherence[1] among users.

“People increasingly want to become more engaged in their own health care, and with Walgreens digital health offerings, we give our customers the ability to positively impact their behaviors and overall health,” said Harry Leider, M.D., chief medical officer, Walgreens. “These latest studies show how active participation and use of digital tools can benefit the user. They can also provide incentives for health plans, employers and payers by helping to reduce health care costs among members.”

Research on Balance Rewards for healthy choices and patients over 50
This study examined the relationship between BRhc engagement and adherence to antihypertensive, oral antidiabetic and antihyperlipidemic medications for patients ages 50 and older. The findings concluded that tracking physical activity four or more times per week were associated with significantly higher – optimal adherence to antihypertensive and antihyperlipidemic medication.[2] In addition, tracking blood pressure twice or more per week or tracking blood glucose once or more per week was associated with significantly better adherence to antihypertensive and oral antidiabetic medications.

Specific findings included:

  • Among BRhc members tracking physical activity, Walgreens observed greater rates of optimal adherence: 11.2 percent higher for antihypertensives, 5.1 percent higher for oral antidiabetics and 4.5 percent higher for antihyperlipidemics.
  • Among BRhc members tracking blood pressure or blood glucose, Walgreens observed greater optimal adherence: 6.8 percent higher for patients taking antihypertensives and 12.3 percent higher for oral antidiabetics.

The Walgreens retrospective cohort study examined patients who filled an antihypertensive, oral antidiabetic or antihyperlipidemic medication among those 50 years old or greater, between March and October 2014.

Research on mobile pill reminders
The other Walgreens study examined the linkage between patient forgetfulness and non-adherence to medications, and the effectiveness of a mobile pill reminder feature. The research found that utilization of the Walgreens mobile app pill reminder was associated with significantly higher optimal adherence to oral antidiabetic, antihypertensive and antihyperlipidemic medications.[3]

Results showed:

  • Among those who used the mobile pill reminder app, Walgreens observed greater optimal adherence: 12.3 percent higher for oral antidiabetics, 11.3 percent higher for antihypertensives and 9.1 percent higher for antihyperlipidemics.

To perform the study, Walgreens took a group comprised of patients who used the pill reminder and had oral antidiabetic, antihypertensive or antihyperlipidemic medications between an index period of January 2014 and September 2014 and compared to a control group comprised of those who did not use the pill reminder.

About Walgreens
Walgreens (www.walgreens.com), one of the nation’s largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and wellbeing enterprise. More than 8 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,173 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens omnichannel business includes Walgreens.com and VisionDirect.com. More than 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

Media Relations:

To contact Walgreens media relations, please email media@walgreens.com or call 847-315-2921.

Source: Walgreens